Study compares pain in transperineal and transrectal approach to prostate biopsy
“So yes, these transperineal biopsies are more painful right in the moment, but immediately following that, these patients are comfortable," says John Myrga, MD.
In this video, John Myrga, MD, discusses the background and relevant findings of his recent study, “Patient Reported Outcomes after Transperineal vs. Transrectal Biopsy with Local Anesthesia: Advances in Pain Control and Areas for Improvement," which was presented at the Northeastern Section of the American Urological Association Annual Meeting. Myrga is a urology resident at University of Pittsburgh Medical Center.
Lenvatinib/pembrolizumab compares favorably with frontline standards in renal cell carcinoma
February 2nd 2024“Combination therapy with lenvatinib plus pembrolizumab provides a comparable OS, and a trend of improvement in PFS and response outcomes, compared with most current global SOC therapies for treatment-naïve patients with advanced renal cell carcinoma,” the study authors wrote.
First-line pembrolizumab/lenvatinib shows efficacy for advanced non–clear cell RCC
January 29th 2024“Updated efficacy and safety results continue to support pembrolizumab plus lenvatinib as a first-line treatment option for patients with advanced non–clear cell RCC,” lead study author Martin H. Voss, MD.
